Dynacare Baby Powder recalled because of potential asbestos contamination

News
Article

The product was sent to distributors by direct delivery in 35 states and Amazon.com.

In a public service announcement, the FDA is sharing Dynarex Corporation's expanded recall of Dynacare Baby Powder, 4 oz and 14 oz because they have the potential to be contaminated with asbestos.

According to Dynarex, the compnay is expanding a recall that began on September 19, 2024, to now include 373 cases of item number 4875 (14 oz) as well as 647 cases of item number 4874 (4 oz).

Dynarex stated that the products were sent to distributors via direct deliver after January 18, 2024, to 35 states and Amazon.com. The states include: AL, AR, AZ, CA, CO, DE, FL, GA, IA, IL, IN, KY, LA, MA, MD, MN, MO, MS, MT, NC, NE, NJ, NM, NY, OH, OK, OR, PA, TN, TX, UT, VA, VT, WA, WI.

Asbestos, a naturally occurring mineral that is typically found near talc, is an ingredient in many cosmetic products, however, it is a known carcinogen with well-documented health risks. "If talc mining sites are not carefully chosen or if proper steps are not taken to adequately purify the talc ore, it may contain asbestos," the company stated in the recall.

Both recalled products are packaged in plastic bottles, in which there are 24 bottles per case for the 14 oz containers and 48 per case for the 4 oz containers. Lot and batch numbers are located on the bottom of the bottle and on each case (pictured below).

As of October 28, 2024, there have been no illnesses or adverse events reported.

Provided by Dynarex, see products and lots of Dynacare Baby Powder below. Consumers should discontinue use immediately and return for a full refund.

Please contact Dynarex Corporation at 888-396-2739 or 845-365-8200 during business hours of 8:30 AM to 5:00 PM Eastern Standard Time, or via email at recall@dynarex.com if you have any questions or need information on how to return the product or receive a full refund.

Product images

All images courtesy of Dynarex Corporation via an FDA MedWatch alert.

Recent Videos
Paul Helmuth, MD
Brittany Bruggeman, MD
Octavio Ramilo
Melissa Fickey, MD
Octavio Ramilo, MD
Brittany Bruggeman, MD
John Loiselle, MD
Brittany Bruggeman, MD
Tina Tan, MD, FAAP, FIDSA, FPIDS
© 2024 MJH Life Sciences

All rights reserved.